Mutagenicity of a series of hexacoordinate chromium (III) compounds

Mutation Research
|October 1, 1981
PubMed

Insights

This study investigated chromium(III) compounds for DNA damage and mutagenicity. Certain chromium compounds with specific aromatic amine ligands show significant genetic toxicity, potentially contributing to chromium carcinogenesis.

Area of Science:

  • Environmental Science
  • Toxicology
  • Genetics

Background:

  • Chromium compounds are known environmental contaminants.
  • The genotoxicity of chromium(III) requires further elucidation.
  • Understanding chromium's mutagenic mechanisms is crucial for risk assessment.

Purpose of the Study:

  • To assess the DNA-damaging and mutagenic potential of 17 chromium(III) compounds.
  • To identify structural features of chromium compounds associated with genotoxicity.
  • To explore the role of chromium(III) in mutagenesis and carcinogenesis.

Main Methods:

  • Utilized the E. coli differential repair assay to evaluate DNA-damaging capabilities.
  • Employed Salmonella typhimurium strains to test for mutagenicity.
  • Synthesized and characterized chromium(III) complexes with varying amine ligands.

Main Results:

  • Four chromium(III) compounds demonstrated activity in both DNA repair and mutagenicity assays.
  • Four additional compounds were positive only in the DNA repair assay.
  • Compounds with aromatic amine ligands (e.g., 2,2'-bipyridine, 1,10-phenanthroline) showed higher activity compared to those with saturated amine ligands.

Conclusions:

  • Chromium(III) can exhibit significant genotoxicity when complexed with appropriate ligands.
  • The ligand environment is critical for the genetic toxicity of chromium(III) compounds.
  • These findings suggest a potential mechanism for chromium-induced mutagenesis and carcinogenesis.

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Properties of Transition Metals02:58

Properties of Transition Metals

Transition metals are defined as those elements that have partially filled d orbitals. As shown in Figure 1, the d-block elements in groups 3–12 are transition elements. The f-block elements, also called inner transition metals (the lanthanides and actinides), also meet this criterion because the d orbital is partially occupied before the f orbitals.
Crystal Field Theory - Octahedral Complexes02:58

Crystal Field Theory - Octahedral Complexes

Crystal Field Theory
To explain the observed behavior of transition metal complexes (such as colors), a model involving electrostatic interactions between the electrons from the ligands and the electrons in the unhybridized d orbitals of the central metal atom has been developed. This electrostatic model is crystal field theory (CFT). It helps to understand, interpret, and predict the colors, magnetic behavior, and some structures of coordination compounds of transition metals.
CFT focuses on...
Colors and Magnetism03:02

Colors and Magnetism

Color in Coordination Complexes
When atoms or molecules absorb light at the proper frequency, their electrons are excited to higher-energy orbitals. For many main group atoms and molecules, the absorbed photons are in the ultraviolet range of the electromagnetic spectrum, which cannot be detected by the human eye. For coordination compounds, the energy difference between the d orbitals often allows photons in the visible range to be absorbed and emitted, which is seen as colors by the human eye.
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...